Načítá se...
Small-molecule agonists for the glucagon-like peptide 1 receptor
The peptide hormone glucagon-like peptide (GLP)-1 has important actions resulting in glucose lowering along with weight loss in patients with type 2 diabetes. As a peptide hormone, GLP-1 has to be administered by injection. Only a few small-molecule agonists to peptide hormone receptors have been de...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
National Academy of Sciences
2007
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1783418/ https://ncbi.nlm.nih.gov/pubmed/17213325 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0605701104 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|